South Korea Lancing Devices for Blood Testing Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Adjustable Depth Lancing Devices, Safety Lancets, and Others), By Application (Diabetes Management, Hemoglobin Testing, Cholesterol Testing, and Others), and South Korea Lancing Devices for Blood Testing Market Insights, Industry Trend, Forecasts to 2035

South Korea Lancing Devices for Blood Testing Market Insights Forecasts to 2035

• The South Korea Lancing Devices for Blood Testing Market size is Expected to Grow at a CAGR of around 5.2% from 2025 to 2035
• The South Korea Lancing Devices for Blood Testing Market size is Expected to hold a significant Share by 2035

According to a research report published by Spherical Insights & Consulting, The South Korea Lancing Devices for Blood Testing Market Size is anticipated to grow at a CAGR of 5.2% from 2025 to 2035. The market is driven by rising prevalence of diabetes and the increasing demand for self-monitoring blood glucose solutions. Additionally, advancements in lancing technologies that minimize pain and improve user convenience further support market growth.

Market Overview

The South Korea market for lancing devices for blood testing consists of spring-loaded and safety-engineered based devices that utilize the lancets to acquire capillary blood primarily as part of blood glucose monitoring. The demand for lancing devices is related to an aging population, nearly universal smart phone penetration, which allows a digital virtual coach to support diabetic protocols, and the hospital protocols and procedures around prevention of infection. Device advancements such as multi-deep adjustable lancing devices, ultra-fine lancing devices, single-use-only safety engineered lancing devices and education can further improve user experience and health outcomes by reducing the users needlestick risk. Strong retail and on-line distribution channels together with diabetes education will help to sustain supply and demand levels to 2035.

Report Coverage

This research report categorizes the market for the South Korea lancing devices for blood testing market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea lancing devices for blood testing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea lancing devices for blood testing market.

Driving Factors

The growth of South Korea lancing devices for blood testing market is driven by increasing diabetes prevalence, higher awareness of early disease management and increasing uptake of self-monitoring blood glucose solutions.  The introduction of new technologies in lancing devices, such as pain-reduction technology, adjustable depth mechanisms, and safety measures increases demand for advancements in lancing devices. With a growing home care landscape, the market has opportunities for growth.

Restraining Factors

The market for lancing devices for blood testing in South Korea is restrained by the high costs of advanced devices, regulatory issues, and the competing technologies in the arena of non-invasive glucose monitoring. The concerns around needle pain, chances of infection, and patient compliance limit market uptake as well.

Market Segmentation

The South Korea lancing devices for blood testing market share is classified into product type and application.

• The adjustable depth lancing devices segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea lancing devices for blood testing market is segmented by product type into adjustable depth lancing devices, safety lancets, and others. Among these, the adjustable depth lancing devices segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to their convenience, customizable penetration depth, and high acceptance for normal glucose monitoring. Safety lancets are coming into prominence, as a result of ease of use and infection control advantages, while category others, relate to specialty devices for use in diagnostics.

• The diabetes management segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea lancing devices for blood testing market is segmented by application into diabetes management, hemoglobin testing, cholesterol testing, and others. Among these, the diabetes management segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. As diabetes is getting increasingly common and patients require frequent self-monitoring blood glucose, awareness of the hemoglobin and cholesterol testing segments is also growing because of health awareness and diagnostic needs. The others segment covers additional applications such as infectious disease testing.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea lancing devices for blood testing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Roche Diagnostics
• Abbott Laboratories
• Becton, Dickinson and Company
• Terumo Corporation
• Sanofi
• Bayer AG
• LifeScan, Inc.
• ARKRAY, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea lancing devices for blood testing market based on the below-mentioned segments:

South Korea Lancing Devices for Blood Testing Market, By Product Type

• Adjustable Depth Lancing Devices
• Safety Lancets
• Others

South Korea Lancing Devices for Blood Testing Market, By Application

• Diabetes Management
• Hemoglobin Testing
• Cholesterol Testing
• Others